Risk factors for methicillin-resistant Staphylococcus aureus in diabetic foot infections
- PMID: 24765246
- PMCID: PMC3984406
- DOI: 10.3402/dfa.v5.23575
Risk factors for methicillin-resistant Staphylococcus aureus in diabetic foot infections
Abstract
Objective: The purpose of this study was to evaluate risk factors for methicillin-resistant Staphylococcus aureus (MRSA) in patients hospitalized for diabetic foot infections.
Methods: We reviewed hospital admissions for foot infections in patients with diabetes which had nasal swabs, and anaerobic and aerobic tissue cultures at the time of admission. Data collected included patient characteristics and medical history to determine risk factors for developing an MRSA infection in the foot.
Results: The prevalence of MRSA in these infections was 29.8%. Risk factors for MRSA diabetic foot infections were history of MRSA foot infection, MRSA nasal colonization, and multidrug-resistant organisms (p<0.05). Positive predictive value (PPV) and negative predictive value (NPV) of nasal colonization with MRSA to identify MRSA diabetic foot infections were 66.7% and 80.0% (sensitivity 41%, specificity 90%). Admission from a nursing home was not a significant risk factor.
Conclusion: Positive nasal swabs are not predictive of the infecting agent; however, a negative nasal swab rules out MRSA as the infecting agent in foot wounds with 90% accuracy.
Keywords: MRSA; diabetic foot; infection; ulcer.
Similar articles
-
Methicillin-resistant Staphylococcus aureus nasal carriage and infection among patients with diabetic foot ulcer.J Microbiol Immunol Infect. 2020 Apr;53(2):292-299. doi: 10.1016/j.jmii.2018.03.005. Epub 2018 Jun 4. J Microbiol Immunol Infect. 2020. PMID: 29907536
-
Evaluation of the negative predictive value of methicillin-resistant Staphylococcus aureus nasal swab screening in patients with acute myeloid leukemia.Infect Control Hosp Epidemiol. 2021 Jul;42(7):853-856. doi: 10.1017/ice.2020.1299. Epub 2020 Nov 24. Infect Control Hosp Epidemiol. 2021. PMID: 33228818
-
Sensitivity and Specificity of prior Methicillin-Resistant Staphylococcus aureus Nasal Swab Results for Predicting Methicillin-Resistant Staphylococcus aureus Infections in Intensive Care Unit Admissions Over a 1-Year Period: A Pilot Study.J Res Pharm Pract. 2021 Jan 11;9(4):208-211. doi: 10.4103/jrpp.JRPP_20_86. eCollection 2020 Oct-Dec. J Res Pharm Pract. 2021. PMID: 33912504 Free PMC article.
-
Methicillin-resistant Staphylococcus aureus in diabetic foot infections.Drugs. 2010 Oct 1;70(14):1785-97. doi: 10.2165/11538070-000000000-00000. Drugs. 2010. PMID: 20836573 Review.
-
Systematic Review of the Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening for MRSA Pneumonia.Ann Pharmacother. 2019 Jun;53(6):627-638. doi: 10.1177/1060028018823027. Epub 2019 Jan 2. Ann Pharmacother. 2019. PMID: 30600697
Cited by
-
The prevalence of methicillin-resistant Staphylococcus aureus among diabetic patients: a meta-analysis.Acta Diabetol. 2019 Aug;56(8):907-921. doi: 10.1007/s00592-019-01301-0. Epub 2019 Apr 6. Acta Diabetol. 2019. PMID: 30955124 Free PMC article.
-
The Global Prevalence of Methicillin-Resistant Staphylococcus Aureus in Patients with Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis.Diabetes Metab Syndr Obes. 2024 Feb 3;17:563-574. doi: 10.2147/DMSO.S446911. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38333763 Free PMC article. Review.
-
Risk Factors for Invasive Methicillin-Resistant Staphylococcus aureus Infection After Recent Discharge From an Acute-Care Hospitalization, 2011-2013.Clin Infect Dis. 2016 Jan 1;62(1):45-52. doi: 10.1093/cid/civ777. Epub 2015 Sep 3. Clin Infect Dis. 2016. PMID: 26338787 Free PMC article.
-
Pathophysiology and Molecular Imaging of Diabetic Foot Infections.Int J Mol Sci. 2021 Oct 26;22(21):11552. doi: 10.3390/ijms222111552. Int J Mol Sci. 2021. PMID: 34768982 Free PMC article. Review.
-
Bacterial Interactions in the Context of Chronic Wound Biofilm: A Review.Microorganisms. 2022 Jul 25;10(8):1500. doi: 10.3390/microorganisms10081500. Microorganisms. 2022. PMID: 35893558 Free PMC article. Review.
References
-
- Lavery LA, Armstrong DG, Murdoch DP, Peters EJ, Lipsky BA. Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis. 2007;44:562–5. - PubMed
-
- Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004;39:885–910. - PubMed
-
- Tentolouris N, Petrikkos G, Vallianou N, Zachos C, Daikos GL, Tsapogas P, et al. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect. 2006;12:186–9. - PubMed
-
- Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:e132–73. - PubMed
-
- Lipsky BA, Peters EJ, Berendt AR, Senneville E, Bakker K, Embil JM, et al. Specific guidelines for the treatment of diabetic foot infections 2011. Diabetes Metab Res Rev. 2012;28(Suppl 1):234–5. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources